Retained Earnings (Accumulated Deficit) of LakeShore Biopharma Co., Ltd. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD and CNY
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: LakeShore Biopharma Co., Ltd. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
LakeShore Biopharma Co., Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Mar 2025 was $335,388,438, a 3.1% decline year-over-year.
LakeShore Biopharma Co., Ltd. quarterly Retained Earnings (Accumulated Deficit) in CNY history and change rate from 31 Mar 2022 to 31 Mar 2025.
LakeShore Biopharma Co., Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Mar 2025 was ¥2,407,485,287, a 4.3% decline year-over-year.
Source SEC data: View on sec.gov

Retained Earnings (Accumulated Deficit), Quarterly (USD)

Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Retained Earnings (Accumulated Deficit), Quarterly (CNY)

Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

LakeShore Biopharma Co., Ltd. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$335,388,438	-$10,159,004	-3.1%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q1 2024	$325,229,434	-$52,511,189	-19%	31 Mar 2024	20-F	15 Aug 2024	2024	FY
Q1 2023	$272,718,245			31 Mar 2023	20-F	26 Jul 2023	2023	FY

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	¥2,407,485,287	-¥99,982,451	-4.3%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q1 2024	¥2,307,502,836	-¥433,464,871	-23%	31 Mar 2024	20-F	31 Jul 2025	2025	FY
Q1 2023	¥1,874,037,965	-¥283,470,802	-18%	31 Mar 2023	20-F	15 Aug 2024	2024	FY
Q1 2022	¥1,590,567,163			31 Mar 2022	20-F	26 Jul 2023	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.